RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+12%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.07B
AUM Growth
+$3.07B
Cap. Flow
-$383M
Cap. Flow %
-12.45%
Top 10 Hldgs %
34.44%
Holding
116
New
6
Increased
34
Reduced
30
Closed
6

Top Buys

1
SMMT icon
Summit Therapeutics
SMMT
$22.8M
2
LLY icon
Eli Lilly
LLY
$18.2M
3
NUVL icon
Nuvalent
NUVL
$17.8M
4
ZBIO
Zenas BioPharma, Inc. Common Stock
ZBIO
$14.9M
5
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
$11.4M

Top Sells

1
BPMC
Blueprint Medicines
BPMC
$156M
2
IDXX icon
Idexx Laboratories
IDXX
$58.2M
3
EVH icon
Evolent Health
EVH
$56.8M
4
BSX icon
Boston Scientific
BSX
$30M
5
ACHC icon
Acadia Healthcare
ACHC
$23M

Sector Composition

1 Healthcare 97.81%
2 Consumer Staples 1.99%
3 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SWTX
76
DELISTED
SpringWorks Therapeutics
SWTX
$6.4M 0.21%
199,855
– –
BHVN icon
77
Biohaven
BHVN
$1.71B
$6.37M 0.21%
127,558
– –
BEAM icon
78
Beam Therapeutics
BEAM
$1.9B
$6.12M 0.2%
249,923
– –
PCRX icon
79
Pacira BioSciences
PCRX
$1.22B
$6.02M 0.2%
400,000
-385,000
-49% -$5.79M
NAMS icon
80
NewAmsterdam Pharma
NAMS
$2.8B
$5.87M 0.19%
+353,319
New +$5.87M
MRSN icon
81
Mersana Therapeutics
MRSN
$34.8M
$5.76M 0.19%
3,046,782
– –
LUNG icon
82
Pulmonx
LUNG
$67.6M
$5.73M 0.19%
691,300
+38,900
+6% +$322K
ABOS icon
83
Acumen Pharmaceuticals
ABOS
$84.2M
$5.7M 0.19%
2,300,059
– –
CATX icon
84
Perspective Therapeutics
CATX
$251M
$5.53M 0.18%
414,396
+13,200
+3% +$176K
PLRX icon
85
Pliant Therapeutics
PLRX
$105M
$4.32M 0.14%
384,996
– –
EPIX icon
86
ESSA Pharma
EPIX
$11.2M
$4.1M 0.13%
677,005
– –
EDAP
87
EDAP TMS
EDAP
$103M
$4M 0.13%
1,568,000
+93,000
+6% +$237K
AUTL
88
Autolus Therapeutics
AUTL
$383M
$3.75M 0.12%
1,032,988
– –
MGNX icon
89
MacroGenics
MGNX
$121M
$3.47M 0.11%
1,053,647
– –
LPTX icon
90
Leap Therapeutics
LPTX
$12M
$3.26M 0.11%
1,266,546
– –
GOSS icon
91
Gossamer Bio
GOSS
$587M
$3.22M 0.1%
3,266,960
– –
ACRS icon
92
Aclaris Therapeutics
ACRS
$223M
$3.17M 0.1%
2,753,495
– –
XLO icon
93
Xilio Therapeutics
XLO
$37.5M
$2.37M 0.08%
3,003,259
– –
APLS icon
94
Apellis Pharmaceuticals
APLS
$3.51B
$2.31M 0.08%
80,000
-60,700
-43% -$1.75M
ADAP
95
Adaptimmune Therapeutics
ADAP
$13.9M
$2.31M 0.08%
2,425,468
– –
SGMT icon
96
Sagimet Biosciences
SGMT
$239M
$2.18M 0.07%
787,808
– –
BMEA icon
97
Biomea Fusion
BMEA
$114M
$1.83M 0.06%
181,147
– –
CGEN icon
98
Compugen
CGEN
$133M
$1.79M 0.06%
989,990
– –
VIGL
99
DELISTED
Vigil Neuroscience
VIGL
$1.6M 0.05%
471,958
– –
SPRB
100
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$1.24M 0.04%
2,609,125
– –
1 2 3
4
5